Results 231 to 240 of about 70,873 (256)
Some of the next articles are maybe not open access.

Chapter 2. Anti-Anxiety Agents, Anticonvulsants and Sedative-Hypnotics

1977
Publisher Summary This chapter describes the metabolic studies of Lorazepam in man and animals, Pinazepams in man, Diazepam in human kidney cortex microsomes and bile, and Nitrazepam in rabbit urine. N-desmethyldiazepam is a new human metabolite of chlorodiazepoxid, e.g Diazepam and its main active metabolite desmethyldiazepam, pass into the breast ...
W HOULIHAN, G BENNETT
openaire   +1 more source

Chapter 1. Antipsychotic and Antianxiety Agents

1972
Publisher Summary This chapter presents results of studies that analyze antipsychotic and antianxiety agents. The use of long-acting fluphenazine in the management of schizophrenia and its comparison with conventional therapy was reviewed. Studies of other 6-6-6 tricyclics included several new phenothiaaine derivatives. A diazabicyclononane analog of
Charles L. Zirkle, Carl Kaiser
openaire   +1 more source

Chapter 2. Anti-Anxiety Agents, Anticonvulsants & Sedative-Hypnotics

1983
Publisher Summary Studies on pharmacotherapy for anxiety continue to evolve along the dual paths of agents and actions. While benzodiazepines (BZs) continue to be the agents of choice for anxiolysis, new series of non-BZ compounds are emerging that may offer alternatives in the management of anxiety disorders.
Joseph P. Yevich   +2 more
openaire   +1 more source

Chapter 2: Anti-Anxiety Agents, Anticonvulsants, and Sedative-Hypnotics

1976
Publisher Summary This chapter includes report of some novel structures of different compounds and its derivatives and analogs that continue to dominate the pharmacologically related areas of anti-anxiety, anticonvulsant, and sedative-hypnotic therapy.
openaire   +1 more source

Chapter 2. Anti-Anxiety Agents, Anticonvulsants, and Sedative-Hypnotics

1982
Publisher Summary This chapter discusses the biochemical mechanisms of action of anxiolytics, anticonvulsants and sedatives, and to a better understanding of the causes and nature of the disorders for which they are used. Strong evidence continues to support a functional link between benzodiazepines (BZ), gamma-aminobutyric acid (GABA), and chloride ...
openaire   +1 more source

Anti-anxiety Properties of Selected Medicinal Plants

Current Pharmaceutical Biotechnology, 2022
Asmatullah Khan   +2 more
exaly  

Anti-anxiety agents.

Journal of the Iowa Medical Society, 1970
openaire   +1 more source

Valerian for anxiety disorders

The Cochrane Library, 2006
Alvaro N Atallah, Bernardo Soares
exaly  

Home - About - Disclaimer - Privacy